1. Home
  2. RGEN vs BWXT Comparison

RGEN vs BWXT Comparison

Compare RGEN & BWXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • BWXT
  • Stock Information
  • Founded
  • RGEN 1981
  • BWXT 1867
  • Country
  • RGEN United States
  • BWXT United States
  • Employees
  • RGEN N/A
  • BWXT N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • BWXT
  • Sector
  • RGEN Health Care
  • BWXT
  • Exchange
  • RGEN Nasdaq
  • BWXT Nasdaq
  • Market Cap
  • RGEN 7.1B
  • BWXT 10.2B
  • IPO Year
  • RGEN N/A
  • BWXT N/A
  • Fundamental
  • Price
  • RGEN $128.50
  • BWXT $100.52
  • Analyst Decision
  • RGEN Buy
  • BWXT Strong Buy
  • Analyst Count
  • RGEN 12
  • BWXT 10
  • Target Price
  • RGEN $177.78
  • BWXT $126.67
  • AVG Volume (30 Days)
  • RGEN 756.1K
  • BWXT 1.0M
  • Earning Date
  • RGEN 04-30-2025
  • BWXT 05-05-2025
  • Dividend Yield
  • RGEN N/A
  • BWXT 1.00%
  • EPS Growth
  • RGEN N/A
  • BWXT 14.55
  • EPS
  • RGEN N/A
  • BWXT 3.07
  • Revenue
  • RGEN $634,439,000.00
  • BWXT $2,703,654,000.00
  • Revenue This Year
  • RGEN $12.24
  • BWXT $14.51
  • Revenue Next Year
  • RGEN $15.24
  • BWXT $9.72
  • P/E Ratio
  • RGEN N/A
  • BWXT $32.50
  • Revenue Growth
  • RGEN 0.33
  • BWXT 8.31
  • 52 Week Low
  • RGEN $113.50
  • BWXT $86.70
  • 52 Week High
  • RGEN $182.52
  • BWXT $136.31
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 34.73
  • BWXT 46.53
  • Support Level
  • RGEN $135.71
  • BWXT $96.11
  • Resistance Level
  • RGEN $147.00
  • BWXT $105.01
  • Average True Range (ATR)
  • RGEN 6.09
  • BWXT 2.65
  • MACD
  • RGEN -1.57
  • BWXT 0.42
  • Stochastic Oscillator
  • RGEN 12.43
  • BWXT 51.25

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About BWXT BWX Technologies Inc.

BWX Technologies Inc is a specialty manufacturer & service provider of nuclear components. It operates in two segments. The government Operations segment consists of legacy Nuclear Operations Group & Nuclear Services Group segments with certain research & development activities in the areas of advanced reactors & advanced manufacturing. The commercial Operations segment consists of the legacy Nuclear Power Group segment with certain research and development & commercialization activities in the areas of medical & industrial radioisotopes & radiopharmaceuticals. The majority is from the Government Operations segment. Geographically, it operates in the United States, Canada & United Kingdom, out of which the majority is from the United States.

Share on Social Networks: